Capital Fund Management (CFM)
VNDA icon

Capital Fund Management (CFM)’s Vanda Pharmaceuticals VNDA Stock Holding History

Capital Fund Management (CFM)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-39,037
Closed -$404K – 1596
2020
Q1 		$404K Sell
39,037
-4,919
-11% -$61K 0.01% 1121
2019
Q4 		$721K Buy
+43,956
New +$665K 0.01% 1236
2017
Q2 		– Sell
-13,900
Closed -$195K – 1763
2017
Q1 		$195K Buy
+13,900
New +$198K ﹤0.01% 1396
2015
Q1 		– Sell
-10,300
Closed -$147K – 1755
2014
Q4 		$147K Buy
+10,300
New +$122K ﹤0.01% 1526

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Capital Fund Management (CFM)'s VNDA Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of Vanda Pharmaceuticals (VNDA) in Q2 2020, closing a stake of 39,037 shares — an estimated $404K sold.

Capital Fund Management (CFM) first reported a position in VNDA in Q4 2014 and held it in 4 quarters. The position peaked at $721K in Q4 2019. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining Vanda Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 39,037 Vanda Pharmaceuticals shares in Q2 2020, an estimated $404K.
  • Capital Fund Management (CFM) first reported a position in Vanda Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s Vanda Pharmaceuticals position peaked at $721K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.